Drug intelligence / Profile preview

Bailixiang herbal tea

Development stage: Unknown
Lead developer: China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica
Administration: Oral

Overview

Bailixiang herbal tea is a traditional Chinese medicine (TCM) preparation derived from thyme (*Thymus vulgaris*). It is being developed by the China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica for the treatment of the common cold. The therapeutic is specifically evaluated for its efficacy and safety in patients presenting with the TCM pattern of wind-cold attacking the exterior accompanied by spleen-stomach disharmony. Thyme is traditionally recognized for its antimicrobial, antitussive, and spasmolytic properties, which are primarily attributed to its essential oil constituents such as thymol and carvacrol.

Other names: Bailixiangthyme herbal tea

Beyond the preview

Go deeper on Bailixiang herbal tea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bailixiang herbal tea.

Explore the full profile